Prediction Case File
YouTubeEvaluation Complete

Zymeworks Inc Stock Prediction and Forecast [ZYME]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.us19 Nov 2025, 04:40 UTC
Video preview for Zymeworks Inc Stock Prediction and Forecast [ZYME]
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

Several short-term signals, along with a general good trend, are positive, indicating a buying opportunity. The stock has shown positive movement recently, with a favorable 3-month MACD signal and bullish moving average crossovers. Short-term analysis suggests a potential upward trend, with key resistance at $25.63 and support at $21.67. Long-term analysis predicts a potential gain of 32.18% over the next three months and 20.38% over the next year. The stock's current price is considered undervalued, with a P/E ratio of -0.0887, suggesting potential for growth despite recent daily volatility and a sell signal from a pivot top.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

StockInvest.us

Tracked signals
1521
Historical success
43.3%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.